AstraZeneca partners with AI company to find cure for cancer
The collaboration aims to create a zero-shot generative AI model that would work on creating new antibody therapeutics and enhancing existing ones.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The collaboration aims to create a zero-shot generative AI model that would work on creating new antibody therapeutics and enhancing existing ones.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
DBS Survey Finds 88% of Businesses Testing or Using Tokenized Money
TL;DR: A DBS survey published October 28 found that 88% of businesses in its sample were deploying or piloting tokenized-money use...
Coinbase Says Customer Funds Safe After Analytics Vendor Contact-Data Incident
TL;DR: Coinbase said an incident involving analytics provider Amplitude affected contact information associated with a small subse...
Binance Confirms $6.3B Security Breach, Freezes $3B in Assets and Pledges Full Compensation
The exchange says blockchain partners have frozen approximately $3 billion in affected assets. Binance has also pledged to cover a...
Google Cloud Previews Institutional Crypto Key-Security Service as Custody Risks Grow
TL;DR: Google Cloud has documented a Multi-party Compute service for institutional digital-asset custody, describing threshold sig...
Binance hot wallet breach affects $6B, customer funds secure
The breach underscores the importance of robust security measures and may influence market confidence and regulatory scrutiny in t...
Canary Staked INJ ETF aims to bring regulated Injective staking to Nasdaq
The proposed ETF could enhance US investor access to crypto staking, but regulatory approval and inherent risks may impact its suc...